Phakomatosis pigmentovascularis: Clinical findings in 15 patients and review of the literature - 24/04/13
, Pablo Boixeda, MD, PhD, Elena de las Heras, MD, PhD, Sonsoles Aboin, MD, Cristina García-Millán, MD, Pedro Jaén Olasolo, MD, PhD
Reprint requests: Montse Fernández-Guarino, MD, Hospital Ramón y Cajal, Carretera de Colmenar Km 9,100, 28034 Madrid, Spain.Abstract |
Introduction |
Phakomatosis pigmentovascularis (PPV) is a rare syndrome characterized by the association of a vascular nevus with an extensive pigmentary nevus.
Objective |
We sought to study and evaluate clinical findings in patients with PPV referred to the laser department of our hospital.
Methods |
We revised the clinical findings of 15 patients with PPV and reclassified them according to Happle’s new classification.
Results |
We studied 11 female patients and 4 male patients with a mean age of 21 years. Thirteen had phakomatosis cesioflammea, one cesiomarmorata, and one an unclassifiable form. Of 15 patients, 12 had nevus of Ota. The vascular involvement was extensive in our PPV population and 14 patients were affected in two or more areas. The mosaicism pattern in 13 patients was patchy and without a midline separation. The most frequent associations found were Sturge-Weber syndrome, Klippel-Trénaunay syndrome, and melanosis oculi.
Limitations |
Limitations include the methods of case collection, that this is a retrospective study, and that there were a relatively small number of patients.
Conclusions |
PPV are rare syndromes with a wide variability in their clinical expression. Most of the publications in the literature have only reported isolated cases.
Le texte complet de cet article est disponible en PDF.Plan
| Funding sources: None. |
|
| Conflicts of interest: None declared. |
Vol 58 - N° 1
P. 88-93 - janvier 2008 Retour au numéro
Article précédent
- A comparison of disease severity among affected male versus female patients with PHACE syndrome
- Denise W. Metry, Dawn H. Siegel, Maria R. Cordisco, Elena Pope, Julie Prendiville, Beth A. Drolet, Kimberly A. Horii, Sarah L. Stein, Ilona J. Frieden
- From the Medical Board of the National Psoriasis Foundation: Monitoring and vaccinations in patients treated with biologics for psoriasis
- Mark Lebwohl, Jerry Bagel, Joel M. Gelfand, Dafna Gladman, Kenneth B. Gordon, Sylvia Hsu, Robert E. Kalb, Alexa Boer Kimball, Neil J. Korman, Gerald G. Krueger, Philip Mease, Warwick L. Morison, Amy Paller, David M. Pariser, Christopher Ritchlin, Bruce Strober, Abby Van Voorhees, Gerald D. Weinstein, Melodie Young, Liz Horn
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?